This week the drug olaparib (also known as Lynparza) was approved for use in Scotland for women with ovarian cancer by the Scottish Medicine’s Consortium. Scottish charity Worldwide Cancer Research funded work which kick-started the development of this drug over 20 years ago.
Trials have shown ...
Read more
We are thrilled to see that a skin cancer project that we kick-started at the University of Sussex and run by Professor John Spencer has received further funding from The Engineering and Physical Sciences Research Council (EPSRC) to take the research to the next step.
The team has been awarded...
Read more
We are delighted to announce that once again, our partners at First Names Group have produced a Christmas video aimed at raising funds for Worldwide Cancer Research. First Names Group is a leading independent provider of trust, fund, real estate and corporate services operating in strategic lo...
Read more
